CASE STUDY: OSSIX Plus

Case 8: Guided bone regeneration, placement of immediate and delayed implants

Dr. Barry Levin, Jenkintown, PA; restoration by Dr. Gregg Rothstein, Richboro, PA.

Patient Presentation

A 57-year-old woman presented with a failing mesial bridge abutment (tooth #6). The treatment plan was to section the fixed partial denture (FPD) #3-#6, extract the carious canine #6, and place 2 dental implants in the positions of teeth #4 & #6.

The premolar implants were placed in conjunction with an osteotome procedure using a composite graft. Upon re-entry for the stage 2 surgery, there were remnants of the OSSIX Plus membrane. A new, implant-supported brige #4-#6 was fabricated, maintaining a single porcelain fused to metal crown #3.

To order any OSSIX product, call OraPharma at 866-273-7846

INDICATION

OSSIX® Bone is a sterile, biocompatible bone grafting material aimed to fill, augment, or reconstruct periodontal and bony defects of the maxillo-facial complex.

IMPORTANT SAFETY INFORMATION:

  • OSSIX® Bone must not be used in:
    • Patients with known collagen hypersensitivity.
    • Patients with a sensitivity to porcine-derived materials.
    • Patients suffering from autoimmune diseases and connective tissue diseases, such as: systemic lupus erythematosus, dermatomyositis, etc.
    • Patients with acute or chronic infection (osteomyelitis) at the surgical site.
    • Patients with vascular impairment at the implant site.
    • Patients with uncontrolled periodontal disease.
    • Patients that have received or are currently receiving treatment with bisphosphonates.
    • OSSIX® Bone should not be used in the presence of infected wounds at the site of implantation.
  • OSSIX® Bone is intended for a single use only. Do not re-sterilize or reuse.
  • As OSSIX® Bone contains collagen, allergic reactions (e.g. erythema, swelling, induration and/or pruritus at treatment site) may not be entirely excluded.

Please see accompanying Instructions for Use or Click here for Instructions for Use.